Metoprololtartraat Accord

Metoprolol Tartrate, the active ingredient in Metoprololtartraat Accord, is a beta blocker presented as various strengths/tablet for oral use. It treats hypertension, angina pectoris, heart failure, myocardial infarction prophylaxis and certain arrhythmias in adult patients. GNH USA supplies Metoprololtartraat Accord as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoprololtartraat Accord is a cardio‑selective beta‑blocker used in several cardiovascular conditions.

- Hypertension: lowers blood pressure by reducing heart rate and cardiac output. - Angina pectoris: decreases myocardial oxygen demand, relieving chest pain. - Heart failure: improves survival and reduces hospitalisations by lowering cardiac workload. - Myocardial infarction prophylaxis: reduces risk of recurrent infarction and mortality. - Arrhythmias: controls heart rate in supraventricular tachycardia and atrial fibrillation.

Metoprololtartraat Accord may cause a range of adverse reactions.

Common Side Effects: - Fatigue: feeling of tiredness or lack of energy. - Dizziness: light‑headed sensation, especially on standing. - Bradycardia: slower than normal heart rate. - Cold extremities: reduced blood flow to hands and feet. - Gastrointestinal upset: nausea, abdominal discomfort. - Depression: mood changes or low mood.

Serious or Rare Side Effects: - Severe bradycardia or heart block requiring medical attention. - Marked hypotension leading to fainting. - Bronchospasm in patients with reactive airway disease. - Worsening heart failure symptoms. - Allergic reactions such as rash or angioedema. - Cardiogenic shock in susceptible individuals.

Before initiating therapy, clinicians should consider several safety measures.

- Monitor blood pressure: ensure adequate control without excessive hypotension. - Assess cardiac function: evaluate for existing heart block or severe bradycardia. - Review concomitant beta‑blockers: avoid additive effects. - Adjust dose in renal impairment: consider reduced clearance. - Avoid abrupt discontinuation: taper gradually to prevent rebound tachycardia. - Store at room temperature: keep in the original pack, protect from moisture and light.

Metoprololtartraat Accord can interact with various medicines; some require avoidance while others need careful monitoring.

Major Interactions (Avoid): - Verapamil or diltiazem: may cause profound bradycardia or heart block. - Clonidine withdrawal: can precipitate severe hypertension. - Insulin or oral hypoglycemics: may mask hypoglycemia symptoms. - Non‑steroidal anti‑inflammatory drugs: can reduce antihypertensive efficacy. - Other antihypertensives: additive hypotensive effect.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: monitor renal function and potassium. - Diuretics: watch for excessive blood pressure drop. - Antidepressants (e.g., SSRIs): observe for heart rate changes. - Antidiabetic agents: adjust glucose monitoring. - Calcium channel blockers (non‑dihydropyridine): monitor cardiac conduction.